Vitamin K2 Market Size & Growth Forecast 2027–2036, By Segments (Dosage Form, Indication, Product, Source, Application, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Vitamin K2 Market size was more than USD 365.15 million in 2026 and is set to grow at a 17.26% CAGR between 2027 and 2036, reaching USD 1.79 billion by 2036. The industry revenue for 2027 is calculated at USD 419.7 million.
Get more details on this report
Request Free Sample ReportVitamin K2 Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 37.99% share in 2026, supported by growing awareness of bone and cardiovascular health, preventive nutrition, and wider access to supplements through retail and online channels.
- Rising health awareness, expanding supplement consumption, and increasing interest in healthy aging are supporting demand, while pharmacies, specialty retailers, and e-commerce platforms improve product accessibility.
Segment Momentum
- Capsules and tablets accounted for 44.57% of the market in 2026, supported by convenience, portability, and familiarity. Their suitability for daily supplementation and consistent nutrient delivery makes them attractive formats for manufacturers targeting consumers focused on nutritional wellness.
- Bone health represented 39.32% of the market in 2026 and is also the fastest-growing indication segment. Growing interest in skeletal strength, calcium utilization, and preventive nutritional care is supporting demand for vitamin K2 supplements targeting long-term bone wellness.
Market Expansion Drivers
- Increasing awareness of bone & cardiovascular health.
- Fortification of foods with Vitamin K2.
- Expansion of dietary supplements in emerging markets.
Leading Market Participants
- Major companies in the vitamin K2 market include DSM-Firmenich (Netherlands), Kappa Bioscience (Norway), BASF (Germany), Kyowa Hakko Bio (Japan), Zhejiang Medicine (China), Gnosis by Lesaffre (Italy), Geneferm Biotechnology (China), Fermenta Biotech (India), Nisshin Pharma (Japan), Novozymes (Denmark).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 365.15 million
- 2027 Estimated Market Size: USD 419.7 million
- Projected Market Size: USD 1.79 billion by 2036
- Growth Forecast: 17.26% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Dosage Form (Capsules/Tablets) | Indication (Bone Health) | Product (MK-7) | Source (Natural) | Application (Health Supplements) | Distribution Channel (Offline)
- Emerging Opportunity Segment: Dosage Form (Capsules/Tablets) | Indication (Bone Health) | Product (MK-7) | Source (Natural) | Application (Health Supplements) | Distribution Channel (Offline)
Market Growth Drivers and Industry Trends
Increasing awareness of bone & cardiovascular health
Growing consumer awareness of the relationship between nutrition and long-term bone and cardiovascular health is encouraging interest in vitamin K2 as a specialized nutritional ingredient. Vitamin K2 is increasingly recognized for its role in calcium metabolism and its relevance to maintaining healthy bones and supporting cardiovascular function. As consumers become more proactive about preventive nutrition and seek targeted dietary solutions, awareness of vitamin K2 is contributing to broader interest across functional nutrition and supplementation applications.
Fortification of foods with Vitamin K2
The incorporation of vitamin K2 into functional foods and beverages is expanding opportunities for consumers to obtain targeted nutrients through everyday dietary products. Food manufacturers are increasingly exploring nutrient fortification as consumers seek convenient ways to support health without relying exclusively on traditional supplements. Advances in formulation and ingredient stability are helping facilitate the inclusion of vitamin K2 in a broader range of products, supporting its adoption in functional nutrition and fortified food applications.
Expansion of dietary supplements in emerging markets
The growing availability of dietary supplements in emerging markets is creating new opportunities for vitamin K2 products as consumers become more familiar with preventive health and specialized nutritional ingredients. Improvements in retail distribution, digital commerce, health awareness, and access to nutritional information are making supplements more accessible to a wider consumer base. As purchasing behavior shifts toward proactive wellness and targeted nutrient intake, the expanding supplement ecosystem is supporting greater adoption of vitamin K2 formulations.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing awareness of bone & cardiovascular health | 5% | Short term (≤ 2 yrs) | North America; Europe; spillover: Asia Pacific | Medium | Fast |
| Fortification of foods with Vitamin K2 | 4% | Medium term (2–5 yrs) | Europe; North America; spillover: Asia Pacific | Medium | Moderate |
| Expansion of dietary supplements in emerging markets | 3% | Long term (5+ yrs) | Asia Pacific; Latin America; spillover: MEA | Low | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for a 37.99% share of the vitamin K2 market in 2026, supported by growing consumer awareness of nutritional health, bone health, cardiovascular wellness, and the role of vitamin K2 in calcium metabolism. Increasing interest in preventive healthcare and dietary supplementation is encouraging consumers to incorporate vitamins and specialized nutrients into daily wellness routines. Demand is also being supported by the growing availability of vitamin K2 through dietary supplements and functional nutrition products, alongside increasing consumer preference for targeted nutritional solutions. Research interest in the relationship between vitamin K2 and bone and cardiovascular health is further contributing to market awareness, while expanding distribution through health-focused retail and online channels is improving product accessibility.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to be the fastest-growing region in the vitamin K2 market, driven by rising health awareness, expanding nutritional supplement consumption, and growing interest in preventive healthcare. Consumers across the region are increasingly seeking products that support bone strength, cardiovascular wellness, and overall nutritional health, creating opportunities for specialized vitamin formulations. The expansion of the middle-class population and increasing healthcare awareness are encouraging greater spending on dietary supplements and functional nutrition products. Growing availability of vitamin K2 through pharmacies, health-focused retail outlets, and e-commerce platforms is also improving consumer access. In addition, increasing awareness of nutritional deficiencies and the importance of maintaining healthy aging and bone health is supporting demand for vitamin K2 products across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Supplement Formulation DemandIn the U.S., vitamin K2 demand is supported by its growing incorporation into bone health, cardiovascular wellness, and combination supplement formulations. Manufacturers are focusing on differentiated dosage formats, scientifically positioned ingredients, and product combinations that improve convenience for wellness-oriented consumers.
Germany 🇩🇪
Quality-Controlled SupplementationGermany’s vitamin K2 market is shaped by strong expectations for ingredient quality, regulatory compliance, and scientifically supported nutritional products. Suppliers are prioritizing standardized raw materials, transparent sourcing, and formulations positioned around bone and cardiovascular health applications.
Japan 🇯🇵
Functional Nutrition IntegrationIn Japan, vitamin K2 benefits from established consumer familiarity with functional nutrition and fermented food-derived ingredients. Commercial activity is centered on incorporating vitamin K2 into supplements and health-focused products that emphasize quality, convenient consumption, and targeted nutritional support.
South Korea 🇰🇷
Wellness Product InnovationSouth Korea’s vitamin K2 market is supported by active consumer interest in preventive wellness and diversified health supplement formats. Manufacturers are expanding product differentiation through combination formulations, convenient delivery formats, and premium positioning linked to bone and broader health maintenance.
France 🇫🇷
Preventive Health FormulationsIn France, vitamin K2 is gaining relevance within preventive nutrition products, particularly formulations associated with bone health and complementary nutrient intake. Suppliers are focusing on clear product positioning, compliant health communication, and combinations with vitamins and minerals used in targeted supplement categories.
Italy 🇮🇹
Nutraceutical Portfolio ExpansionItaly’s vitamin K2 market is supported by demand for nutraceutical products addressing bone health and healthy aging. Manufacturers are increasingly incorporating the ingredient into combination supplements, with commercial differentiation centered on formulation quality, convenient delivery, and specialized health-oriented product portfolios.
Vitamin K2 Market Share (%), by Dosage Form, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportDosage Form Segment Analysis: Capsules/Tablets (Largest & Fastest-Growing Segment)
The capsules/tablets segment accounted for a 44.57% share of the vitamin K2 market in 2026, supported by the convenience, portability, and familiarity of these dosage forms among consumers seeking nutritional supplementation. Capsules and tablets provide a practical way to incorporate vitamin K2 into regular supplementation routines while allowing manufacturers to formulate products with consistent nutrient content and controlled dosing. Their ease of storage and consumption also makes them suitable for daily use across different consumer groups. Growing awareness of the role of vitamin K2 in supporting calcium metabolism and skeletal health is encouraging demand for convenient supplementation formats. In addition, the availability of vitamin K2 through dietary supplement products and increasing consumer preference for easy-to-administer nutritional products are strengthening adoption. Improvements in formulation technologies and the incorporation of vitamin K2 into broader bone and cardiovascular health supplement offerings are expected to further support the segment's position as both the largest and fastest-growing dosage form.
Indication Segment Analysis: Bone Health (Largest & Fastest-Growing Segment)
The bone health segment accounted for a 39.32% share of the vitamin K2 market in 2026 and represents both the largest and fastest-growing indication segment, reflecting increasing consumer and healthcare interest in nutrients associated with maintaining skeletal strength and supporting calcium utilization. Vitamin K2 plays an important role in the activation of proteins involved in bone mineralization, making it increasingly relevant to nutritional approaches focused on maintaining bone health. Growing awareness of age-related bone deterioration and the importance of preventive nutritional care is supporting demand for vitamin K2 products targeted toward skeletal wellness. The expanding interest in supplementation that addresses bone health through complementary nutrients is also creating opportunities for vitamin K2. Furthermore, increasing adoption of preventive healthcare practices and greater consumer attention to long-term nutritional wellness are expected to sustain demand for vitamin K2 products positioned around bone health applications.
Product Segment Analysis: MK-7 (Largest & Fastest-Growing Segment)
The MK-7 segment represents both the largest and fastest-growing product segment in the vitamin K2 market, supported by its strong relevance in nutritional supplementation and growing recognition of its suitability for sustained vitamin K2 intake. MK-7 is commonly incorporated into dietary supplements because of its favorable characteristics for maintaining vitamin K2 availability in the body, supporting its use in products focused on bone and cardiovascular wellness. Increasing consumer awareness of different vitamin K2 forms is encouraging demand for specialized formulations that provide targeted nutritional benefits. The growing emphasis on preventive health and long-term supplementation is also strengthening interest in MK-7-based products. In addition, advancements in ingredient formulation, improved product stability, and broader incorporation of MK-7 into supplements containing complementary ingredients are expanding its applications across the nutritional products landscape, supporting continued growth of this product segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Dosage Form | Capsules/Tablets, Softgels, Liquid, Others | Capsules/Tablets | Capsules/Tablets |
| Indication | Bone Health, Heart Health, Blood Clotting, Others | Bone Health | Bone Health |
| Product | MK-7, MK-4 | MK-7 | MK-7 |
| Source | Natural, Synthetic | Natural | Natural |
| Application | Health Supplements, Functional Foods and Beverages | Health Supplements | Health Supplements |
| Distribution Channel | Offline, Online | Offline | Offline |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Market credibility in the vitamin K2 sector hinges on rigorous quality control, verifiable synthesis methods, and scientific validation. Whether utilizing natural fermentation or synthetic routes, suppliers must deliver high all-trans isomer purity—particularly for MK-7—supported by transparent analytical documentation to guarantee biological activity and regulatory compliance. Beyond raw ingredient purity, addressing formulation stability within complex food matrices and supplement delivery systems is essential for preserving potency across intended shelf lives. Furthermore, as health claims regarding bone and cardiovascular support face stringent regulatory oversight, competitive leadership shifts toward suppliers that back their ingredients with robust clinical science and transparent claim substantiation to navigate distinct global market standards.
Major players in the vitamin K2 market:
- DSM-Firmenich (Netherlands)
- Kappa Bioscience (Norway)
- BASF (Germany)
- Kyowa Hakko Bio (Japan)
- Zhejiang Medicine (China)
- Gnosis by Lesaffre (Italy)
- Geneferm Biotechnology (China)
- Fermenta Biotech (India)
- Nisshin Pharma (Japan)
- Novozymes (Denmark)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| DSM-Firmenich (Netherlands) | |||||||
| Kappa Bioscience (Norway) | |||||||
| BASF (Germany) | |||||||
| Kyowa Hakko Bio (Japan) | |||||||
| Zhejiang Medicine (China) | |||||||
| Gnosis by Lesaffre (Italy) | |||||||
| Geneferm Biotechnology (China) | |||||||
| Fermenta Biotech (India) | |||||||
| Nisshin Pharma (Japan) | |||||||
| Novozymes (Denmark) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Balchem | March 2026 | A clinical trial demonstrated that daily supplementation of 240 micrograms of Balchem's K2VITAL improved neuromuscular signalling in adults aged 65 and older following resistance exercise. These findings provide clinical evidence supporting the application of the vitamin K2 ingredient in healthy aging and performance-oriented nutrition. |
| SunWay Biotech | March 2024 | SunWay Biotech and Gnosis by Lesaffre formed a strategic alliance to launch MenaQ7 Metabolic, a specialized vitamin K2 product. The collaboration combines the companies' expertise to advance product development activities in targeted nutritional supplementation for heart and bone health. |
| Balchem Corp. | June 2022 | Balchem Corp. announced an agreement to acquire Kappa Bioscience, a market-leading producer of vitamin K2. This strategic acquisition aligns with Balchem's corporate vision of expanding health and wellness solutions by integrating specialized vitamin K2 capabilities into its existing nutritional portfolio. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Vitamin K2 Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Target Consumer Group | Adults, Seniors, Women, Athletes & Active Adults |
| Dosage Strength | Low-Dose, Standard-Dose, High-Dose |
| Certification Standard | Non-Certified, GMP-Certified, Organic-Certified, Third-Party Tested |
Vitamin K2 Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Bioavailability & Formulation Positioning |
|
| Regulatory & Health-Claim Pathways |
|
| Clinical Evidence Commercialization |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the total addressable market for vitamin K2?
How is the vitamin K2 industry expected to grow over the next 10 years?
How is rising awareness of bone and cardiovascular health strengthening demand for vitamin K2 products?
How is the expansion of fortified foods and dietary supplements broadening vitamin K2 adoption?
Why do capsules and tablets lead the vitamin K2 market?
How is bone health driving demand for vitamin K2 products?
Why does North America lead the vitamin K2 market?
What is driving the rapid growth of the vitamin K2 market in Asia Pacific?
Who are the leading players in the vitamin K2 landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook